Shopping Cart
- Remove All
- Your shopping cart is currently empty
NPS2390 is a first generation quinoxaline derivative that acts as a noncompetitive antagonist of mGluR1 and mGluR5 (IC50 of 5.2 and 82 nM, respectively)
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $35 | In Stock | |
10 mg | $58 | In Stock | |
25 mg | $113 | In Stock | |
50 mg | $197 | In Stock | |
100 mg | $323 | In Stock | |
200 mg | $445 | In Stock |
Description | NPS2390 is a first generation quinoxaline derivative that acts as a noncompetitive antagonist of mGluR1 and mGluR5 (IC50 of 5.2 and 82 nM, respectively) |
Targets&IC50 | mGluR5:82 nM, mGluR1:5.2nM |
In vitro | Treatment of NPS2390 was conducive to inhibit the proliferation and reverse phenotypic modulation of PASMCs by regulating autophagy levels. |
Molecular Weight | 307.39 |
Formula | C19H21N3O |
Cas No. | 226878-01-9 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 3.07 mg/mL (10 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.